Cargando…

Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation

BACKGROUND AND PURPOSE: Tumor recurrence after liver transplantation (LT) impedes the curative chance for hepatocellular carcinoma (HCC) patients. This study aimed to develop a deep pathomics score (DPS) for predicting tumor recurrence after liver transplantation using deep learning. PATIENTS AND ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qu, Wei-Feng, Tian, Meng-Xin, Lu, Hong-Wei, Zhou, Yu-Fu, Liu, Wei-Ren, Tang, Zheng, Yao, Zhao, Huang, Run, Zhu, Gui-Qi, Jiang, Xi-Fei, Tao, Chen-Yang, Fang, Yuan, Gao, Jun, Wu, Xiao-Ling, Chen, Jia-Feng, Zhao, Qian-Fu, Yang, Rui, Chu, Tian-Hao, Zhou, Jian, Fan, Jia, Yu, Jin-Hua, Shi, Ying-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386986/ https://www.ncbi.nlm.nih.gov/pubmed/37031334 http://dx.doi.org/10.1007/s12072-023-10511-2

Ejemplares similares

Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma
por: Tian, Meng-Xin, et al.
Publicado: (2019)

Predicting peritoneal recurrence in gastric cancer with serosal invasion using a pathomics nomogram
por: Chen, Dexin, et al.
Publicado: (2023)

Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis
por: Liu, Wei-Ren, et al.
Publicado: (2020)

Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in Colorectal Cancer
por: Cao, Rui, et al.
Publicado: (2020)

Prognostic and predictive value of a pathomics signature in gastric cancer
por: Chen, Dexin, et al.
Publicado: (2022)

Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection
por: Liu, Wei-Ren, et al.
Publicado: (2020)

Exploring pathological signatures for predicting the recurrence of early-stage hepatocellular carcinoma based on deep learning
por: Qu, Wei-Feng, et al.
Publicado: (2022)

Extending the landscape of omics technologies by pathomics
por: Bülow, Roman D., et al.
Publicado: (2023)

PATHOME: an algorithm for accurately detecting differentially expressed subpathways
por: Nam, S, et al.
Publicado: (2014)

Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study
por: Zhu, Gui‐Qi, et al.
Publicado: (2021)

Next-Generation Morphometry for pathomics-data mining in histopathology
por: Hölscher, David L., et al.
Publicado: (2023)

Recent advances of pathomics in colorectal cancer diagnosis and prognosis
por: Wu, Yihan, et al.
Publicado: (2023)

Palliative Gastrectomy versus Gastrojejunostomy for advanced Gastric cancer with outlet obstruction: a propensity score matching analysis
por: Chen, Xiao-Jiang, et al.
Publicado: (2021)

RAM score is an effective predictor for early mortality and recurrence after hepatectomy for hepatocellular carcinoma
por: Hsu, Heng-Yuan, et al.
Publicado: (2017)

Scoring Selection Criteria Including Total Tumour Volume and Pretransplant Percentage of Lymphocytes to Predict Recurrence of Hepatocellular Carcinoma after Liver Transplantation
por: Li, Chuan, et al.
Publicado: (2013)

Clinical use of machine learning‐based pathomics signature for diagnosis and survival prediction of bladder cancer
por: Chen, Siteng, et al.
Publicado: (2021)

Radio-pathomic approaches in pediatric neuro-oncology: Opportunities and challenges
por: Familiar, Ariana M, et al.
Publicado: (2023)

SDPS-41 PATHOMICS AUGMENTS PREDICTIVE SURVIVAL MODELLINGIN MEDULLOBLASTOMA
por: Mahtabfar, Aria, et al.
Publicado: (2023)

Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study
por: Qu, Wei-Feng, et al.
Publicado: (2022)

Application of ablative therapy for intrahepatic recurrent hepatocellular carcinoma following hepatectomy
por: Cong, Rong, et al.
Publicado: (2023)

Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma
por: Gu, Jing-Xian, et al.
Publicado: (2019)

The Performance of GALAD Score for Diagnosing Hepatocellular Carcinoma in Patients with Chronic Liver Diseases: A Systematic Review and Meta-Analysis
por: Guan, Ming-Cheng, et al.
Publicado: (2023)

Prevalence and determinants of sufficient fruit and vegetable consumption among primary school children in Nakhon Pathom, Thailand
por: Hong, Seo Ah, et al.
Publicado: (2017)

SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma
por: Yang, Yu-Feng, et al.
Publicado: (2018)

CD36(+) cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor
por: Zhu, Gui-Qi, et al.
Publicado: (2023)

Integrating pathomics with radiomics and genomics for cancer prognosis: A brief review
por: Lu, Cheng, et al.
Publicado: (2021)

Liver resection versus transplantation for multiple hepatocellular carcinoma: a propensity score analysis
por: Li, Chuan, et al.
Publicado: (2017)

Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma
por: Ni, Xiao-Chun, et al.
Publicado: (2015)

Laparoscopic vs. Open Repeat Hepatectomy for Recurrent Liver Tumors: A Propensity Score–Matched Study and Meta-Analysis
por: Chen, Jia-Feng, et al.
Publicado: (2021)

Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma
por: Tian, Meng-Xin, et al.
Publicado: (2019)

Cystathionine β-synthase mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesis
por: Zhou, Yu-Fu, et al.
Publicado: (2021)

Deciphering intratumoral heterogeneity of hepatocellular carcinoma with microvascular invasion with radiogenomic analysis
por: Wang, Yi, et al.
Publicado: (2023)

Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
por: Fu, Yi-Peng, et al.
Publicado: (2016)

Towards Generation, Management, and Exploration of Combined Radiomics and Pathomics Datasets for Cancer Research
por: Saltz, Joel, et al.
Publicado: (2017)

Corrigendum to Integrating pathomics with radiomics and genomics for cancer prognosis: A brief review
Publicado: (2021)

SDPS-40 MEDULLOBLASTOMA MOLECULAR SUBTYPE PREDICTION USING PATHOMIC FEATURE ANALYSIS
por: Mahtabfar, Aria, et al.
Publicado: (2023)

PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-Catenin signaling in hepatocellular carcinoma
por: Yang, Yu-Feng, et al.
Publicado: (2017)

Recurrence of Hepatocellular Carcinoma With Epithelial–Mesenchymal Transition After Spontaneous Regression: A Case Report
por: Yang, Shi-zhong, et al.
Publicado: (2015)

A Novel Nomogram Based on Machine Learning-Pathomics Signature and Neutrophil to Lymphocyte Ratio for Survival Prediction of Bladder Cancer Patients
por: Chen, Siteng, et al.
Publicado: (2021)

Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study
por: Yang, Yi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_66qe8p3f3abcmqj3af126bc7i0